non-muscle Myosin IIA Antibody

About the Target

Non-muscle myosin IIA (NM IIA), encoded by the MYH9 gene, is a motor cytoskeletal enzyme critical for diverse cellular processes from embryogenesis to adulthood. As a hexameric complex, NM IIA comprises two heavy chains and four light chains-two essential (ELC) and two regulatory (RLC)-organized into three structural regions: the motor domain (containing ATP- and actin-binding sites), neck domain (where light chains bind), and tail domain. Depending on the literature source, MYH9 may also be discussed as non-muscle Myosin IIA and Myosin-9.

Reported cellular context includes cellmembrane, cytoplasm, cytoplasmicvesicle, and cytoskeleton, which can matter when signal is compared across treatments or changing cell states. Following MYH9 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

MYH9 is commonly interpreted in the context of developmental biology research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cellmembrane, cytoplasm, and cytoplasmicvesicle, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between cellmembrane, cytoplasm, and cytoplasmicvesicle across matched conditions
• stage-dependent patterns during differentiation, morphogenesis, or lineage commitment
• co-patterning with orthogonal markers and control conditions that clarify pathway state
• time-matched comparisons so changes reflect biology rather than handling or sampling drift

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for MYH9. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in MYH9 reflect biology rather than handling. When interpreting MYH9, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep MYH9 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.